USP <797> Understanding Changes with Sterile Compounding in Hospitals

Contact Our Team

Webinar

Date:8/15/2019
Start Time:12:00 AM
End Time:12:00 AM
Contact Information
Additional:
Additional Information
Description:

Provided by MHA Health Institute
Health Institute

Date & Time

Thursday, Aug. 15
Noon to 1:15 p.m.

Register on or before Wednesday, Aug. 14, to ensure delivery of instructional materials.

Once registered, you will receive a confirmation email with instructions on how to join. Invite colleagues to join you — one connection per facility is encouraged.

This complimentary webinar is being offered through a generous contribution from MHA Management Services Corporation.


Audience

CEOs; CFOs; COOs; directors of pharmacy; and nursing, compliance, housekeeping, regulation and accreditation staff


Overview

The United States Pharmacopeia Convention finalized revisions to the USP <797> guidelines. Knowledge of these changes in the standardization process for the preparation of sterile compounded drugs are essential for pharmacists, pharmacy technicians and nurses who are involved with any aspect of the compounding process.

The purpose of this knowledge-based activity is to review regulatory requirements surrounding sterile drug preparation. Hospital administration and support departments should have a basic understanding of the regulatory requirements to support compliance.


Objectives

  • describe the current regulatory oversight of compounded drugs in the U.S. and Missouri
  • identify the elements of an effective USP <797> sterile compounding environment and technique
  • describe strategies to ensure compliance with new USP <797> guidelines


Faculty

Nathan Hanson, Pharm.D., M.S., BCPS
Division Director of Pharmacy Operations — MidAmerica Division
HealthTrust Supply Chain
Shawnee, Kan.

Nathan Hanson, Pharm.D., M.S., BCPS, is the division director of pharmacy operations for the HealthTrust Purchasing Group. In this role, Hanson serves the HCA MidAmerica Division in the areas of controlled substance management, sterile compounding, The Joint Commission readiness, pharmacy distribution and leadership development. He is leading the USP <800> readiness efforts for the division, and he co-authored the USP <800> guidance document that is the pattern for policies, procedures and job aids at 185 HCA hospitals.

He is actively involved with the ASHP Section of Pharmacy Practice Managers and the MSHP Public Policy Committee, and he serves on the Missouri Board of Pharmacy Hospital Advisory Committee.

Hanson holds a Doctor of Pharmacy from Drake University, and a master’s degree in pharmacy administration from the University of Kansas. He completed his Health System Pharmacy Administration PGY1/PGY2 residency at KU Medical Center and is a Board Certified Pharmacotherapy Specialist.


For More Information

Contact Peggy Taylor at ptaylor@mhanet.com or 573/893-3700, ext.1370 with questions.